280 related articles for article (PubMed ID: 31911155)
1. Old wine in new bottles: Advanced drug delivery systems for disulfiram-based cancer therapy.
McMahon A; Chen W; Li F
J Control Release; 2020 Mar; 319():352-359. PubMed ID: 31911155
[TBL] [Abstract][Full Text] [Related]
2. Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers.
Chen W; Yang W; Chen P; Huang Y; Li F
ACS Appl Mater Interfaces; 2018 Dec; 10(48):41118-41128. PubMed ID: 30444340
[TBL] [Abstract][Full Text] [Related]
3. Disulfiram: A Food and Drug Administration-approved multifunctional role in synergistically drug delivery systems for tumor treatment.
Xu L; Sun Y; Li Y; Sun J; Guo Y; Shen Q; Wei Q; Shen JW
Int J Pharm; 2022 Oct; 626():122130. PubMed ID: 36007849
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents.
Kannappan V; Ali M; Small B; Rajendran G; Elzhenni S; Taj H; Wang W; Dou QP
Front Mol Biosci; 2021; 8():741316. PubMed ID: 34604310
[TBL] [Abstract][Full Text] [Related]
5. Biomimetic metal-organic nanoparticles prepared with a 3D-printed microfluidic device as a novel formulation for disulfiram-based therapy against breast cancer.
Chang Y; Jiang J; Chen W; Yang W; Chen L; Chen P; Shen J; Qian S; Zhou T; Wu L; Hong L; Huang Y; Li F
Appl Mater Today; 2020 Mar; 18():. PubMed ID: 34746366
[TBL] [Abstract][Full Text] [Related]
6. Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent.
Wehbe M; Anantha M; Shi M; Leung AW; Dragowska WH; Sanche L; Bally MB
Int J Nanomedicine; 2017; 12():4129-4146. PubMed ID: 28615941
[TBL] [Abstract][Full Text] [Related]
7. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.
Ren L; Feng W; Shao J; Ma J; Xu M; Zhu BZ; Zheng N; Liu S
Theranostics; 2020; 10(14):6384-6398. PubMed ID: 32483459
[TBL] [Abstract][Full Text] [Related]
8. Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems.
Kang X; Jadhav S; Annaji M; Huang CH; Amin R; Shen J; Ashby CR; Tiwari AK; Babu RJ; Chen P
Pharmaceutics; 2023 May; 15(6):. PubMed ID: 37376016
[TBL] [Abstract][Full Text] [Related]
9. Sphingomyelin-based PEGylation Cu (DDC)
Liu H; Kong Y; Liu Z; Guo X; Yang B; Yin T; He H; Gou J; Zhang Y; Tang X
Int J Pharm; 2022 Jun; 621():121788. PubMed ID: 35504431
[TBL] [Abstract][Full Text] [Related]
10. Leveraging disulfiram to treat cancer: Mechanisms of action, delivery strategies, and treatment regimens.
Lu Y; Pan Q; Gao W; Pu Y; Luo K; He B; Gu Z
Biomaterials; 2022 Feb; 281():121335. PubMed ID: 34979419
[TBL] [Abstract][Full Text] [Related]
11. Prospective clinical trial of disulfiram plus copper in men with metastatic castration-resistant prostate cancer.
Zhang T; Kephart J; Bronson E; Anand M; Daly C; Spasojevic I; Bakthavatsalam S; Franz K; Berg H; Karachaliou GS; James OG; Howard L; Halabi S; Harrison MR; Armstrong AJ; George DJ
Prostate; 2022 May; 82(7):858-866. PubMed ID: 35286730
[TBL] [Abstract][Full Text] [Related]
12. Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy.
Chen M; Huang Z; Xia M; Ding Y; Shan T; Guan Z; Dai X; Xu X; Huang Y; Huang M; Zhao C
J Control Release; 2022 Jan; 341():351-363. PubMed ID: 34856225
[TBL] [Abstract][Full Text] [Related]
13. Differential Cytotoxicity Mechanisms of Copper Complexed with Disulfiram in Oral Cancer Cells.
Chen SY; Chang YL; Liu ST; Chen GS; Lee SP; Huang SM
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918312
[TBL] [Abstract][Full Text] [Related]
14. A disulfiram/copper gluconate co-loaded bi-layered long-term drug delivery system for intraperitoneal treatment of peritoneal carcinomatosis.
Wang P; Luo Q; Zhang L; Qu X; Che X; Cai S; Liu Y
Colloids Surf B Biointerfaces; 2023 Nov; 231():113558. PubMed ID: 37776774
[TBL] [Abstract][Full Text] [Related]
15. Highly Stable, Coordinated Polymeric Nanoparticles Loading Copper(II) Diethyldithiocarbamate for Combinational Chemo/Chemodynamic Therapy of Cancer.
Peng X; Pan Q; Zhang B; Wan S; Li S; Luo K; Pu Y; He B
Biomacromolecules; 2019 Jun; 20(6):2372-2383. PubMed ID: 31117352
[TBL] [Abstract][Full Text] [Related]
16. The combination of disulfiram and copper for cancer treatment.
Li H; Wang J; Wu C; Wang L; Chen ZS; Cui W
Drug Discov Today; 2020 Jun; 25(6):1099-1108. PubMed ID: 32320854
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the accumulation of disulfiram and its copper complex in A549 cells using mass spectrometry.
Lu X; Lin B; Xu N; Huang H; Wang Y; Lin JM
Talanta; 2020 May; 211():120732. PubMed ID: 32070566
[TBL] [Abstract][Full Text] [Related]
18. Activate the endogenous Cu
Liang X; Li C; Yuan W; Ji M; Zhang J; Yan M; Lu Q; Gou J; Yin T; He H; Tang X; Zhang Y
Int J Pharm; 2024 Mar; 652():123800. PubMed ID: 38218507
[TBL] [Abstract][Full Text] [Related]
19. Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial.
Jakola AS; Werlenius K; Mudaisi M; Hylin S; Kinhult S; Bartek J; Salvesen Ø; Carlsen SM; Strandéus M; Lindskog M; Löfgren D; Rydenhag B; Carstam L; Gulati S; Solheim O; Bartek J; Solheim T
F1000Res; 2018; 7():1797. PubMed ID: 30647912
[No Abstract] [Full Text] [Related]
20. Development of a copper-clioquinol formulation suitable for intravenous use.
Wehbe M; Malhotra AK; Anantha M; Lo C; Dragowska WH; Dos Santos N; Bally MB
Drug Deliv Transl Res; 2018 Feb; 8(1):239-251. PubMed ID: 29247315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
